Concepedia

Elisabeth Bolton-Gillespie

EB

Statistics

Publications

5

Citations

376

H-Index

5

Active since

2013

Affiliations

Temple University(Current)

Medical University of Warsaw

Ludwig Boltzmann Institute for Cardiovascular Research

University of Pennsylvania

Postgraduate School of Molecular Medicine

Elisabeth Bolton-Gillespie is an author at Temple University specializing in molecular oncology, cancer genetics, and oncology.

ORCID

Publications per year

2013–2018

5

Publications

5

Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells

Elisabeth Bolton-Gillespie, Mirle Schemionek, Hans‐Ulrich Klein et al. · Blood · 2013 · 132 citations · Full text

, , +12

Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells

Katherine Sullivan-Reed, Elisabeth Bolton-Gillespie, Yashodhara Dasgupta et al. · Cell Reports · 2018 · 98 citations · Full text

, , +17

Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells

Margaret Nieborowska-Skorska, Katherine Sullivan, Yashodhara Dasgupta et al. · Journal of Clinical Investigation · 2017 · 76 citations · Full text

, , +17

Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases

Yashodhara Dasgupta, Mateusz Koptyra, Grażyna Hoser et al. · Blood · 2016 · 52 citations · Full text

, , +15

Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expression

Eunsun Kim, Ying Cheng, Elisabeth Bolton-Gillespie et al. · The Journal of Experimental Medicine · 2017 · 18 citations · Full text

, , +17

1–5 of 5